The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
A benzothiazine that is piroxicam in which the pyridin-2-yl group is replaced by a 5-methyl-1,3-thiazol-2-yl group. A non-steroidal anti-inflammatory drug and selective inhibitor of COX-2, it is used particularly for the management of rheumatoid arthritis.
Meloxicam inhibits the reaction [Doxorubicin results in increased activity of ABCB1 protein]; Meloxicam inhibits the reaction [Doxorubicin results in increased expression of ABCB1 protein]
Meloxicam results in increased activity of CASP3 protein [Rutin co-treated with Meloxicam] affects the reaction [Formaldehyde affects the expression of CASP3 protein]; Meloxicam affects the reaction [Formaldehyde affects the expression of CASP3 protein]; Meloxicam inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein] Meloxicam inhibits the reaction [Diquat results in increased expression of CASP3 protein modified form] [Meloxicam co-treated with Cilostazol] results in increased activity of CASP3 protein
Meloxicam inhibits the reaction [Diquat results in increased expression of CASP9 protein modified form] Meloxicam results in increased activity of CASP9 protein [Meloxicam co-treated with Cilostazol] results in increased activity of CASP9 protein
meloxicam inhibits the reaction [Doxorubicin results in decreased activity of CAT protein] Meloxicam results in decreased expression of CAT protein Meloxicam affects the expression of and affects the activity of CAT protein
[CYP1A2 protein results in increased metabolism of and results in increased susceptibility to Meloxicam] which results in increased chemical synthesis of Pyruvaldehyde; CYP1A2 protein results in increased metabolism of and results in increased susceptibility to Meloxicam
[meloxicam results in decreased activity of PTGS2 protein] inhibits the reaction [trans-10,cis-12-conjugated linoleic acid results in increased expression of EREG mRNA]
Meloxicam inhibits the reaction [HMGB1 protein results in increased expression of PTGS2 protein]; Meloxicam inhibits the reaction [HMGB1 protein results in increased phosphorylation of MAPK1 protein]; Meloxicam inhibits the reaction [HMGB1 protein results in increased phosphorylation of MAPK3 protein]; Meloxicam inhibits the reaction [HMGB1 protein results in increased phosphorylation of NFKBIA protein]
[Rutin co-treated with Meloxicam] affects the reaction [Formaldehyde affects the expression of IL1B protein]; Meloxicam affects the reaction [Formaldehyde affects the expression of IL1B protein]
meloxicam results in increased expression of PTGS2 protein [Meloxicam results in decreased activity of PTGS2 protein] which results in decreased abundance of Dinoprostone; [Meloxicam results in decreased activity of PTGS2 protein] which results in decreased susceptibility to Chlorpyrifos; Meloxicam inhibits the reaction [HMGB1 protein results in increased expression of PTGS2 protein] meloxicam results in decreased activity of PTGS2 protein [meloxicam results in decreased activity of PTGS2 protein] inhibits the reaction [trans-10,cis-12-conjugated linoleic acid results in increased chemical synthesis of Dinoprost]; [meloxicam results in decreased activity of PTGS2 protein] inhibits the reaction [trans-10,cis-12-conjugated linoleic acid results in increased expression of EREG mRNA]; meloxicam inhibits the reaction [Aluminum results in increased expression of PTGS2 mRNA]; meloxicam inhibits the reaction [Aluminum results in increased expression of PTGS2 protein] Meloxicam inhibits the reaction [Diquat results in increased expression of PTGS2 protein]; Meloxicam inhibits the reaction [PTGS2 protein results in increased chemical synthesis of Dinoprostone]
[Rutin co-treated with Meloxicam] inhibits the reaction [Formaldehyde affects the activity of SORD protein]; Meloxicam inhibits the reaction [Formaldehyde affects the activity of SORD protein]